Itraconazole 1% | Terbinafine HCl 1% | Tea Tree Oil 3%
Itraconazole 1% | Terbinafine HCl 1% | Tea Tree Oil 3% is a dermatology-focused preparation for prescriber-directed skin protocols. Ingredient selection should reflect the patient's diagnosis, skin type, tolerability, pregnancy status, and treatment goal.
Itraconazole 1% | Terbinafine HCl 1% | Tea Tree Oil 3% is a compounded topical antifungal preparation combining two pharmacologically distinct systemic-class antifungal agents and a natural antimicrobial essential oil for prescriber-directed treatment of superficial fungal infections including onychomycosis (nail fungus), tinea pedis, tinea corporis, and cutaneous candidiasis. Genesis Compounding prepares this as a prescription-only, patient-specific, 503A compounded preparation not FDA-approved as a compounded product.
| Active Ingredient | Pharmacologic Role |
|---|---|
| Itraconazole 1% | Triazole antifungal that inhibits fungal 14α-demethylase (CYP51), blocking ergosterol biosynthesis, disrupting cell membrane permeability and causing accumulation of toxic 14α-methyl sterols. |
| Terbinafine HCl 1% | Allylamine antifungal that inhibits squalene epoxidase, blocking ergosterol synthesis and causing intracellular squalene accumulation with fungicidal effects, particularly against dermatophytes. |
| Tea Tree Oil 3% | Melaleuca alternifolia-derived essential oil whose primary active component (terpinen-4-ol) disrupts fungal cell membrane permeability and integrity, inhibits fungal respiration and membrane ATPase, and exerts additional anti-inflammatory and antibacterial activity. |
Route: Topical. Apply to the affected nail(s) and surrounding skin once or twice daily as directed. For onychomycosis: cleanse and dry the nail thoroughly; apply to the nail plate, surrounding nail folds, and hyponychium (under-nail rim). A nail file may be used to thin the nail surface before application to improve penetration. Avoid contact with eyes. For skin infections: apply a thin layer to the affected area plus a small margin of surrounding skin.
Dosing is prescriber-determined:
- Typically applied once or twice daily to affected nails or skin for the duration prescribed.
- Onychomycosis treatment may require extended therapy (several months) corresponding to nail growth rate.
- Prescribers may combine with nail debridement to improve topical penetration.
- Itraconazole 1%: Inhibits fungal cytochrome P450-dependent 14α-demethylase (CYP51), blocking the conversion of lanosterol to ergosterol. This disrupts fungal cell membrane composition and permeability, causing accumulation of toxic 14α-methyl sterols and inhibiting fungal growth. Broad spectrum against dermatophytes, Candida, and non-dermatophyte molds.
- Terbinafine HCl 1%: Competitively inhibits fungal squalene epoxidase at an earlier step in the ergosterol pathway, causing intracellular squalene accumulation that is fungicidal (toxic to fungal cells) while simultaneously blocking ergosterol production. Especially effective against dermatophytes.
- Tea Tree Oil 3%: Terpinen-4-ol (the principal bioactive) and α-terpineol disrupt fungal plasma membrane permeability, causing leakage of intracellular contents, inhibiting membrane-associated ATPase (responsible for proton expulsion), and inhibiting mycelial-to-yeast morphogenic conversion. Also exerts anti-inflammatory effects by suppressing TNF-α and IL-1β production.
This triple-combination topical targets the ergosterol biosynthesis pathway at two distinct enzymatic steps (itraconazole at 14α-demethylase, terbinafine at squalene epoxidase), providing synergistic antifungal activity. Tea tree oil adds complementary membrane-disrupting and anti-inflammatory activity. Prescriber-directed for patient-specific management of dermatophyte onychomycosis, tinea pedis/corporis/cruris, and mixed fungal infections not adequately treated by a single-agent topical.
Monitoring: Clinical assessment of nail/skin improvement at 4–8-week intervals; nail culture if no improvement at 12 weeks; assess for local contact sensitization (tea tree oil allergy).
Contraindications:
- Known hypersensitivity to itraconazole, terbinafine, tea tree oil, or formulation components.
Warnings & Precautions:
- Tea tree oil: may cause allergic contact dermatitis in sensitized individuals; oxidized tea tree oil has higher sensitization risk — use fresh preparation.
- Topical itraconazole/terbinafine at these concentrations have minimal systemic absorption; systemic drug interactions are not expected.
- Avoid application to broken or severely inflamed skin.
- Do not use near eyes or mucous membranes.
Drug Interactions:
- Systemic itraconazole and terbinafine carry significant drug interaction profiles; at topical concentrations systemic interactions are negligible, but report all concurrent medications to the prescriber.
Common Side Effects: Mild local burning, erythema, or irritation at application site; contact dermatitis (particularly from tea tree oil in sensitized patients).
Store at room temperature (15°C–25°C). Keep tightly sealed and protected from light (tea tree oil and itraconazole are light-sensitive). Do not freeze. Use within the beyond-use date assigned by Genesis Compounding. Discard if product changes color or odor significantly.
Why are two different antifungals combined in this formula?
Itraconazole and terbinafine inhibit ergosterol synthesis at two different enzymatic steps — providing synergistic antifungal coverage. This dual-pathway targeting is particularly useful for resistant or mixed fungal infections, or for patients who have not responded to single-agent therapy.
What does tea tree oil add to the antifungal formula?
Tea tree oil's active component (terpinen-4-ol) disrupts fungal cell membranes through a different mechanism than either itraconazole or terbinafine, adding a third line of antifungal activity. It also has anti-inflammatory properties that may reduce associated irritation.
How long does treatment take for nail fungus?
Onychomycosis treatment typically requires months of consistent application corresponding to nail growth rates (approximately 6 months for fingernails, 12 months for toenails). Your prescriber will define the treatment duration and assess response over time.
Is this FDA-approved?
No. This is a patient-specific, prescriber-directed 503A compounded preparation from Genesis Compounding, not FDA-approved as a compounded drug.
Will this cause an allergic reaction?
Tea tree oil can cause contact dermatitis in sensitized individuals. If you develop increasing redness, itching, or a rash at the application site, discontinue use and contact your prescriber.
Clinical References
Authoritative sources reviewed in preparing this clinical summary. Provided for prescriber reference; not a substitute for the prescriber’s clinical judgment.